Efficacy observation and prognosis analysis of EGFR-TKIs alone versus EGFR-TKIs plus chemotherapy in advanced lung adenocarcinoma with EGFR Exon 19 Deletion, Exon 21 L858R mutation: A historical cohort study

The aim of this study was to investigate the clinical efficacy and determine the prognostic value of Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKIs) alone versus EGFR-TKIs plus chemotherapy for the treatment of advanced lung adenocarcinoma with EGFR Exon 19 Deletion(19Del), Ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jinhua, Qin, Hongya, Miao, Jianlong, Liu, Ruijuan, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313250/
https://www.ncbi.nlm.nih.gov/pubmed/37390279
http://dx.doi.org/10.1097/MD.0000000000034110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313250/
https://www.ncbi.nlm.nih.gov/pubmed/37390279
http://dx.doi.org/10.1097/MD.0000000000034110

Ejemplares similares